XML 16 R7.htm IDEA: XBRL DOCUMENT v3.22.2.2
Consolidated Statements of Changes in Stockholders' Equity - USD ($)
$ in Thousands
Total
Cumulative Effect, Period of Adoption, Adjustment [Member]
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Retained Earnings [Member]
Cumulative Effect, Period of Adoption, Adjustment [Member]
Accumulated Other Comprehensive Income (Loss), Net [Member]
Noncontrolling Interest [Member]
Cumulative effect adjustment $ 108,200   $ 66,771 $ 252 $ 40,688   $ 264 $ 225
Beginning Balance at Dec. 31, 2020 108,200   $ 66,771 252 40,688   264 225
Beginning Balance, Shares at Dec. 31, 2020     8,577,932          
Net income 39,685       39,684     1
Other comprehensive net (loss) income 2,019           2,019  
Dividends on common stock (7,183)       (7,183)      
Issuance of common stock and other consideration paid in business combination 125,403   $ 125,403          
Issuance of common stock and other consideration paid in business combination, Shares     9,951,743          
Stock option exercises 748   $ 748          
Stock option exercises, Shares     83,647          
Restricted stock awards, net of forfeitures 848   $ 848          
Restricted stock awards, net of forfeitures, Shares     162,985          
Ending Balance at Sep. 30, 2021 269,720   $ 193,770 252 73,189   2,283 226
Ending Balance, Shares at Sep. 30, 2021     18,776,307          
Cumulative effect adjustment 266,826   $ 193,259 252 70,885   2,200 230
Beginning Balance at Jun. 30, 2021 266,826   $ 193,259 252 70,885   2,200 230
Beginning Balance, Shares at Jun. 30, 2021     18,631,073          
Net income 6,806       6,810     (4)
Other comprehensive net (loss) income 83           83  
Dividends on common stock (4,506)       (4,506)      
Stock option exercises, Shares     750          
Restricted stock awards, net of forfeitures 511   $ 511          
Restricted stock awards, net of forfeitures, Shares     144,484          
Ending Balance at Sep. 30, 2021 269,720   $ 193,770 252 73,189   2,283 226
Ending Balance, Shares at Sep. 30, 2021     18,776,307          
Cumulative effect adjustment 269,720   $ 193,770 252 73,189   2,283 226
Cumulative effect adjustment 277,139 [1] $ 3,542 194,309 252 85,982 $ 3,542 (3,632) 228
Beginning Balance at Dec. 31, 2021 277,139 [1] $ 3,542 $ 194,309 252 85,982 $ 3,542 (3,632) 228
Beginning Balance, Shares at Dec. 31, 2021     18,774,082          
Net income 21,610       21,609   1
Other comprehensive net (loss) income (45,748)           (45,748)  
Dividends on common stock (6,854)       (6,854)      
Stock option exercises $ 14   $ 14          
Stock option exercises, Shares 1,183   1,183          
Restricted stock awards, net of forfeitures $ 997   $ 997          
Restricted stock awards, net of forfeitures, Shares     168,803          
Dividend reinvestment plan issuances 31   $ 31          
Dividend reinvestment plan issuances, shares     2,200          
Disposition of noncontrolling interest (229)             (229)
Ending Balance at Sep. 30, 2022 250,502   $ 195,351 252 104,279   (49,380) 0
Ending Balance, Shares at Sep. 30, 2022     18,946,268          
Cumulative effect adjustment 261,660   $ 195,053 252 103,846   (37,491)  
Beginning Balance at Jun. 30, 2022 261,660   $ 195,053 252 103,846   (37,491)  
Beginning Balance, Shares at Jun. 30, 2022     18,761,848          
Net income 2,736       2,736      
Other comprehensive net (loss) income (11,889)           (11,889)  
Dividends on common stock (2,303)       (2,303)      
Restricted stock awards, net of forfeitures 267   $ 267          
Restricted stock awards, net of forfeitures, Shares     182,220          
Dividend reinvestment plan issuances 31   $ 31          
Dividend reinvestment plan issuances, shares     2,200          
Ending Balance at Sep. 30, 2022 250,502   $ 195,351 252 104,279   (49,380) 0
Ending Balance, Shares at Sep. 30, 2022     18,946,268          
Cumulative effect adjustment $ 250,502   $ 195,351 $ 252 $ 104,279   $ (49,380) $ 0
[1] Derived from audited December 31, 2021 Consolidated Financial Statements.